This Week in Pediatric Oncology

Uncategorized

Episodes

Friday Jun 21, 2019

Guest host Dr. Ryan Roberts welcomes Rebecca Johnson and Becca Jacobsen to a conversation about the benefits and contributions of AYA (Adolescent/Young Adult) psycho-social support programs which serve the needs and challenges within this demographic of cancer patients and survivors.

Wednesday Mar 06, 2019

Host, Dr. Timothy Cripe from Nationwide Children's Hospital, along with co-host - Dr. Nilay Shah, are joined by Dr. Robert Wechsler-Reya from Sanford Burnham Prebys in San Diego, CA. They discuss Dr. Wechsler-Reya's work including the process, benefits, and limitations of tumor models in mice, as well as research behind the humanized mouse model. They also discuss immune evasion - how one tumor type can grow in the presence of an immune system, while another one cannot. Listen in to learn more.
Please send questions and comments to TWiPO@solvingkidscancer.org.

Thursday May 25, 2017

TWiPO hosts and cohosts interview Dr. Uri Tabori about the challenges that are unique to pediatric brain tumors, and how preventative treatment and early diagnosis can be largely beneficial.  

Thursday May 25, 2017

TWIPO hosts and cohosts interview Dr. Matthew Breen, NC State Veterinary Medicine, to explore the question "Can dogs teach us new tricks when it comes to cancer treatment?"

Thursday May 25, 2017

TWIPO hosts and cohosts interview Dr. Joshua Mendell, UT Southwestern Medical Center, who shares his knowledge with regard to the relationship between innate RNA biology and how it influences human disease.  

Wednesday Oct 01, 2014

New York, NY -- In the most recent episode of This Week in Pediatric Oncology (TWiPO), the first podcast focusing on pediatric cancer research, co-hosts Dr. Edwin Horwitz (Nationwide Children’s Hospital), Dr. Nilay Shah (Nationwide Children’s Hospital),  Dr. Robyn Dennis (Nationwide Children's Hospital), interview Dr.  Carl E. Allen, (Texas Children’s Cancer and Hematology Centers) about his research in a rare pediatric blood disorder known as Langerhans cell histiocytosis (LCH).Dr. Allen is Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology - Baylor College of Medicine, and the Co-Director of the Histiocytosis and Lymphoma Programs at Texas Children's Cancer and Hematology Centers.  His primary research is focused on the clinical and biologic aspects of LCH.  Along with Dr. Kenneth McClain, Dr. Carl Allen has developed the largest Histiocytosis Center in the world.  Dr. Allen has developed gene expression and proteomic strategies to analyze the identity and function of the cells that cause LCH.  The ultimate goal of these experiments is to identify genes, proteins, and pathways that may be used to diagnose and cure patients with LCH.  These experiments may also provide insight into dendritic cell biology and tumor immunology.In this 20-minute episode, Dr. Allen gives an overview of LCH, as well as treatment and the future of LCH research. 

Thursday Jul 10, 2014

New York – This Week in Pediatric Oncology presents the first of a series of interviews from the recent Advances in Neuroblastoma Research meeting, which was held in Cologne, Germany, in May. Co-hosts Dr. Nilay Shah (Nationwide Children’s Hospital) and Dr. Keri Stretby (Nationwide Children’s Hospital) caught up with two pediatric oncologists who’ve made significant advances in neuroblastoma research. In this 25-minute interview, Dr. Robert Seeger (Children's Hospital of Los Angeles) and Dr. Garrett Brodeur (Children’s Hospital of Philadelphia) discuss how the discovery of the MYCN gene 30 years ago has helped scientists better understand neuroblastoma and impacted treatment options.

Copyright 2014 . All rights reserved.

Podcast Powered By Podbean

Version: 20230822